Heuck C C, Erbe I, Flint-Hansen P
Clin Chem. 1983 Jan;29(1):120-5.
The intensity of scattered light varies with the size of the scattering particles. Studying the quantitative immunonephelometric determination of apolipoprotein A-1 (apo A-1), we observed that the different particle sizes of lipoproteins must be taken into account in immunonephelometry if apo A-1 is a constituent of the lipoprotein particles. Because interaction between large lipoproteins and immunocomplexes of high-density lipoproteins increases light scattering nonspecifically, false estimations may be obtained in serum with excessive hyperlipoproteinemia. Furthermore, the accessibility of antigenic sites of apo A-1 in intact high-density lipoproteins is limited. Immunonephelometry of apo A-1 in serum necessitates therefore the elimination of various interferents, which we have achieved by a single one-step extraction of lipids in a two-phase liquid system. With n-hexanol/polyfluoro-polychloro-polyethylene, about 90% of the serum lipids are extracted and only apolipoprotein B is precipitated at the interphase. This pretreatment eliminates the interferences caused by excessive hypertriglyceridemia and therefore greatly facilitates the endpoint immunonephelometry of apo A-1 in normal and pathological serum samples.
散射光的强度随散射颗粒的大小而变化。在研究载脂蛋白A-1(apo A-1)的定量免疫比浊法测定时,我们观察到,如果apo A-1是脂蛋白颗粒的组成成分,那么在免疫比浊法中必须考虑脂蛋白不同的颗粒大小。由于大脂蛋白与高密度脂蛋白免疫复合物之间的相互作用会非特异性地增加光散射,因此在严重高脂血症的血清中可能会得到错误的估计值。此外,完整高密度脂蛋白中apo A-1抗原位点的可及性有限。因此,血清中apo A-1的免疫比浊法需要消除各种干扰物,我们通过在双相液体系统中进行一步脂质提取实现了这一点。使用正己醇/聚氟-聚氯-聚乙烯,约90%的血清脂质被提取,只有载脂蛋白B在相间沉淀。这种预处理消除了由严重高甘油三酯血症引起的干扰,因此极大地促进了正常和病理血清样本中apo A-1的终点免疫比浊法测定。